Ozempic is delivered through a pre-filled, multi-dose pen designed for simplicity
FDA Adverse Event Reporting System (FAERS) data may include reports of musculoskeletal symptoms in patients using GLP-1 receptor agonists, though these reports do not establish causation and may reflect coincidental timing rather than a true drug effect
Both semaglutide and tirzepatide have delivered impressive results in clinical studies, but they differ slightly in their overall effectiveness
Its the shift in how obesity medicines may soon be delivered
Reviews in Endocrine & Metabolic Disorders, 23(3), 521539
Signs of an Ozempic face can include sunken eyes, hollow cheeks, sagging skin, and wrinkles